254
Views
3
CrossRef citations to date
0
Altmetric
Articles

Green formulation, characterization, antifungal and biological safety evaluation of terbinafine HCl niosomes and niosomal gels manufactured by eco-friendly green method

, , , , , , , , & show all
Pages 2325-2352 | Received 10 Jun 2022, Accepted 16 Jul 2022, Published online: 25 Jul 2022

References

  • Gill TM. Beauty shop politics: African American women's activism in the beauty industry. Illinois: University of Illinois Press; 2010.
  • Westmore MG. Camouflage and makeup preparations. Clin Dermatol. 2001;19(4):406–412.
  • Zuber TJ, Baddam K. Superficial fungal infection of the skin: where and how it appears help determine therapy. Postgrad Med. 2001;109(1):117–132.
  • Welsh O, Vera-Cabrera L, Welsh E. Onychomycosis. Clin Dermatol. 2010;28(2):151–159.
  • Darkes MJ, Scott LJ, Goa KL. Terbinafine. Am J Clin Dermatol. 2003;4(1):39–65.
  • Balfour JA, Faulds D. Faulds terbinafine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in superficial mycoses. Drugs. 1992;43(2):259–284. https://doi.org/10.2165/00003495-199243020-00010.
  • Balfour JA, Faulds D. Terbinafine. Drugs. 1992;43(2):259–284.
  • Mirshekari M, Bagheri Ghomi A, Mehravaran A. Smart terbinafine recent nano-advances in delivery of terbinafine. Nanomed J. 2021;8(4):241–254.
  • Souto E, Müller R. Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. J Microencapsul. 2006;23(4):377–388.
  • Salve P. Development and evaluation of topical drug delivery system for terbinafine hydrochloride using niosomes. Res J Topic Cosmet Sci. 2011;2(2):52–63.
  • Hashemi SMH, Enayatifard R, Akbari J, et al. Venlafaxine HCl encapsulated in niosome: green and eco-friendly formulation for the management of pain. AAPS PharmSciTech. 2022;23(5):149.
  • Saeedi M, Morteza-Semnani K, Akbari J, et al. Brain targeting of venlafaxine HCl as a hydrophilic agent prepared through green lipid nanotechnology. J Drug Delivery Sci Technol. 2021;66:102813.
  • Sathali AAH, Rajalakshmi G. Evaluation of transdermal targeted niosomal drug delivery of terbinafine hydrochloride. Int J PharmTech Res. 2010;2(3):2081–2089.
  • Pervaiz F, Mushtaq R, Noreen S. Formulation and optimization of terbinafine HCl loaded chitosan/xanthan gum nanoparticles containing gel: ex-vivo permeation and in-vivo antifungal studies. J Drug Delivery Sci Technol. 2021;66:102935.
  • Chen Y-C, Liu D-Z, Liu J-J, et al. Development of terbinafine solid lipid nanoparticles as a topical delivery system. Int J Nanomed. 2012;7:4409.
  • Patel KK, Kumar P, Thakkar HP. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel. AAPS Pharmscitech. 2012;13(4):1502–1510.
  • Ning M, Guo Y, Pan H, et al. Preparation, in vitro and in vivo evaluation of liposomal/niosomal gel delivery systems for clotrimazole. Drug Dev Ind Pharm. 2005;31(4–5):375–383.
  • Enayatifard R, Akbari J, Saeedi M, et al. Investigating the effect of coated lipid nano particles of spironolactone with chitosan on their properties. J Mazandaran Univ Med Sci. 2018;28(162):25–36.
  • Boskabadi M, Saeedi M, Akbari J, et al. Topical gel of vitamin A solid lipid nanoparticles: a hopeful promise as a dermal delivery system. Adv Pharm Bull. 2021;11(4):663–674.
  • Akbari J, Saeedi M, Enayatifard R, et al. Curcumin niosomes (curcusomes) as an alternative to conventional vehicles: a potential for efficient dermal delivery. J Drug Delivery Sci Technol. 2020;60:102035.
  • Saeedi M, Akbari J, Semnani K, et al. Controlling atorvastatin release from liquisolid systems. J Dispersion Sci Technol. 2022;43(3):375–310.
  • Iman M, Rostamkalaei SS, Ataee R. Percutaneous absorption enhancer properties of Lavandula angustifolia essential oil on percutaneous absorption of naproxen sodium from topical gel, 2021.
  • Abdelkader H, Farghaly U, Moharram H. Effects of surfactant type and cholesterol level on niosomes physical properties and in vivo ocular performance using timolol maleate as a model drug. J Pharmaceut Invest. 2014;44(5):329–337.
  • Ramezani V, Vatanara A, Najafabadi AR, et al. A comparative study on the physicochemical and biological stability of IgG1 and monoclonal antibodies during spray drying process. Daru. 2014;22(1):31–37.
  • Hashemi M, Ramezani V, Seyedabadi M, et al. Formulation and optimization of oral mucoadhesive patches of myrtus communis by box behnken design. Adv Pharm Bull. 2017;7(3):441–450.
  • Tavano L, Mazzotta E, Muzzalupo R. Innovative topical formulations from diclofenac sodium used as surfadrug: the birth of diclosomes. Colloids Surf B Biointerfaces. 2018;164:177–184.
  • Varshosaz J, Pardakhty A, Hajhashemi V-I, et al. Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery. Drug Deliv. 2003;10(4):251–262.
  • Moazeni E, Gilani K, Sotoudegan F, et al. Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery. J Microencapsul. 2010;27(7):618–627.
  • Mishra V, Bansal KK, Verma A, et al. Solid lipid nanoparticles: emerging colloidal nano drug delivery systems. Pharmaceutics. 2018;10(4):191.
  • Morteza-Semnani K, Saeedi M, Akbari J, et al. Development of a novel nanoemulgel formulation containing cumin essential oil as skin permeation enhancer. Drug Deliv Transl Res. 2022;12(6):1455–1407.
  • Enayatifard R, Akbari J, Babaei A, et al. Anti-microbial potential of nano-emulsion form of essential oil obtained from aerial parts of Origanum vulgare L. as food additive. Adv Pharm Bull. 2021;11(2):327–334.
  • Taymouri S, Varshosaz J. Effect of different types of surfactants on the physical properties and stability of carvedilol nano-niosomes. Adv Biomed Res. 2016;5(1):48.
  • Tajbakhsh M, Saeedi M, Morteza-Semnani K, et al. Innovation of testosome as a green formulation for the transdermal delivery of testosterone enanthate. J Drug Delivery Sci Technol. 2020;57:101685.
  • Nasseri B. Effect of cholesterol and temperature on the elastic properties of niosomal membranes. Int J Pharm. 2005;300(1-2):95–101.
  • Mokhtar M, Sammour OA, Hammad MA, et al. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm. 2008;361(1-2):104–111.
  • Palozza P, Muzzalupo R, Trombino S, et al. Solubilization and stabilization of β-carotene in niosomes: delivery to cultured cells. Chem Phys Lipids. 2006;139(1):32–42.
  • Shah P, Goodyear B, Haq A, et al. Evaluations of quality by design (QbD) elements impact for developing niosomes as a promising topical drug delivery platform. Pharmaceutics. 2020;12(3):246.
  • Bayindir ZS, Yuksel N. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci. 2010;99(4):2049–2060.
  • El-Samaligy M, Afifi N, Mahmoud E. Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. Int J Pharm. 2006;308(1-2):140–148.
  • New RR. Liposomes. IRL at Oxford University Press; 1990.
  • Shinde U, Pokharkar S, Modani S. Design and evaluation of microemulsion gel system of nadifloxacin. Indian J Pharm Sci. 2012;74(3):237–247.
  • Bousmina M. Rheology of polymer blends: linear model for viscoelastic emulsions. Rheol Acta. 1999;38(1):73–83.
  • Binder L, Mazál J, Petz R, et al. The role of viscosity on skin penetration from cellulose ether‐based hydrogels. Skin Res Technol. 2019;25(5):725–734.
  • Bouwstra JA, Honeywell-Nguyen PL, Gooris GS, et al. Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res. 2003;42(1):1–36.
  • Rambharose S, Kalhapure RS, Jadhav M, et al. Exploring unsaturated fatty acid cholesteryl esters as transdermal permeation enhancers. Drug Deliv Transl Res. 2017;7(2):333–345.
  • Tavano L, Alfano P, Muzzalupo R, et al. Niosomes vs microemulsions: new carriers for topical delivery of capsaicin. Colloids Surf B Biointerfaces. 2011;87(2):333–339.
  • Mukherjee B, Satapathy BS, Bhattacharya S, et al. Chapter 19 - Pharmacokinetic and pharmacodynamic modulations of therapeutically active constituents From orally administered nanocarriers Along With a glimpse of their advantages and limitations. In: Grumezescu AM, editor. Nano- and microscale drug delivery systems. Amsterdam, Netherlands: Elsevier; 2017. p. 357–375.
  • Ghafelehbashi R, Akbarzadeh I, Yaraki MT, et al. Preparation, physicochemical properties, in vitro evaluation and release behavior of cephalexin-loaded niosomes. Int J Pharm. 2019;569:118580.
  • Khoee S, Yaghoobian M. Niosomes: a novel approach in modern drug delivery systems. In: Nanostructures for drug delivery. Amsterdam, Netherlands: Elsevier; 2017. p. 207–237.
  • Garg A, Sharma GS, Goyal AK, et al. Recent advances in topical carriers of anti-fungal agents. Heliyon. 2020;6(8):e04663-e04663. PubMed
  • Gupta M, Vaidya B, Mishra N, et al. Effect of surfactants on the characteristics of fluconazole niosomes for enhanced cutaneous delivery. Artif Cells Blood Substit Immobil Biotechnol. 2011;39(6):376–384.
  • Albash R, Ragaie MH, Hassab MAE, et al. Fenticonazole nitrate loaded trans-novasomes for effective management of tinea corporis: design characterization, in silico study, and exploratory clinical appraisal. Drug Deliv. 2022;29(1):1100–1111.
  • ElMeshad AN, Mohsen AM. Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans via a novel nanosystem vesicle. Drug Deliv. 2016;23(7):2115–2123.
  • Mahant S, Kumar S, Nanda S, et al. Microsponges for dermatological applications: perspectives and challenges. Asian J Pharm Sci. 2020;15(3):273–291.
  • Radmard A, Saeedi M, Morteza-Semnani K, et al. An eco-friendly and green formulation in lipid nanotechnology for delivery of a hydrophilic agent to the skin in the treatment and management of hyperpigmentation complaints: Arbutin niosome (arbusome). Colloids Surf B Biointerfaces. 2021;201:111616.
  • Draize J, Woodward G, Calvery O. Methods for the study of toxicity and irritation of substance applied locally to the skin surface and mucous membrane. J Pharm Col ExpTher. 1994;82:377–390.
  • Goyal G, Garg T, Malik B, et al. Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv. 2015;22(8):1027–1042.
  • El-Ridy MS, Yehia SA, Mohsen AM, et al. Formulation of niosomal gel for enhanced transdermal lornoxicam delivery: in-vitro and in-vivo evaluation. CDD. 2018;15(1):122–133.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.